These authors share senior authorship.
Article first published online: 27 MAR 2012
Copyright © 2012 American Association for the Study of Liver Diseases
Volume 55, Issue 4, pages 1282–1291, April 2012
How to Cite
Fede, G., Spadaro, L., Tomaselli, T., Privitera, G., Germani, G., Tsochatzis, E., Thomas, M., Bouloux, P.-M., Burroughs, A. K. and Purrello, F. (2012), Adrenocortical dysfunction in liver disease: A systematic review. Hepatology, 55: 1282–1291. doi: 10.1002/hep.25573
Potential conflict of interest: Nothing to report.
Abbreviations: ACTH, adreno-cortico-tropic-hormone; AI, adrenal insufficiency; ALF, acute liver failure; CBG, corticosteroid-binding globulin; CIRCI, critical illness-related corticosteroid insufficiency; CLD, chronic liver disease; CRH, corticotrophin-releasing hormone; FAGA, functional adrenal gland atrophy; FCI, free cortisol index; HDL, high-density lipoprotein; HPA, hypothalamus-pituitary-adrenal; ICU, intensive care unit; IIT, insulin-induced hypoglycemia test; IL, interleukin; IV, intravenously; LDL, low-density lipoprotein; LDSST, low-dose short Synacthen test; LT, liver transplant; MAP, mean arterial pressure; MELD, model for end-stage liver disease; PBC, primary biliary cirrhosis; RAI, relative adrenal insufficiency; RR, relative risk; SST, Short Synacthen test; TNF-a, tumor necrosis factor alpha.
- Issue published online: 27 MAR 2012
- Article first published online: 27 MAR 2012
- Accepted manuscript online: 11 JAN 2012 04:50AM EST
- Manuscript Accepted: 16 DEC 2011
- Manuscript Received: 12 JUL 2011
Additional Supporting Information may be found in the online version of this article.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.